Abstract
Objectives: To determine the outcome of patients undergoing distal pancreatectomy for pancreatic adenocarcinoma. Methods: A retrospective review of 39 patients undergoing distal pancreatectomy for adenocarcinoma. Results: Thirty patients underwent surgery for ductal adenocarcinoma, 5 for malignant intraductal papillary mucinous neoplasm and 4 for mucinous cystadenocarcinoma. Malignant cystic neoplasms were significantly less likely to demonstrate perineural invasion, more likely to be well-differentiated, of lower T stage and of lower AJCC staging compared to ductal adenocarcinoma. These had a longer median disease-specific survival (42 (3–144) vs. 15 (14–16) months, p = 0.002). Eight patients underwent extended resections. These were associated with longer operating times compared to standard resections but there was no difference in surgical morbidity or mortality, blood transfusions, length of hospitalization or long-term survival. Univariate analysis demonstrated that R2 resection, size >30 mm, lymph node involvement, need for perioperative blood transfusion, serum albumin <40 g/l and platelet count <200/µl were predictors of survival for ductal adenocarcinoma. Conclusions: Malignant cystic neoplasms have less aggressive behavior and more favorable outcome compared to ductal adenocarcinoma. R2 resection, larger tumor size, lymph node involvement, perioperative transfusion, decreased serum albumin and low platelet count are factors associated with decreased survival in patients with ductal adenocarcinoma undergoing distal pancreatectomy.
References
1.
Nakase A, Matsumoto Y, Uchidak K, Honjo I: Surgical treatment of cancer of the pancreas and periampullary region: Cumulative results in 57 institutions in Japan. Ann Surg 1977;185:52–57.
2.
Johnson CD, Flechtmacker J, Trede M: Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg 1993;80:1177–1179.
3.
Christein JD, Kendrick ML, Iqbal CW, Nagorney DM, Farnell MB: Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg 2005;9:922–927.
4.
Shoup M, Conlon KC, Klimstra D, Brennan MF: Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg 2003;7:946–952.
5.
Dalton RR, Sarr MG, van Heerden JA, Colby TV: Carcinoma of the body and tail of the pancreas: Is curative resection justified? Surgery 1992;111:489–494.
6.
Crist DW, Sitzmann JV, Cameron JL: Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358–365.
7.
Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, et al: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248–257.
8.
Balcom JH 4th, Rattner DW, Warshaw AL, Chang Y, Fernandex-del Castillo C: Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 2001;136:391–398.
9.
Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL: En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 2002;6:147–158.
10.
Goh BK, Tan YM, Cheow PC, Chung YF, Chow PK, Wong WK, Ooi LL: Cystic neoplasms of the pancreas with mucin-production. Eur J Surg Oncol 2005;31:282–287.
11.
Green FL, Page DL, Fleming ID, et al (eds): AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002.
12.
Bergenfeldt M, Moesgaard F, Burcharth F: Curative resection for left-sided pancreatic malignancy. HPB 2006;8:211–215.
13.
Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82:111–115.
14.
Fabre JM, Houry S, Manderscheid JC, Huguier M, Baumel H: Surgery for left-sided pancreatic cancer. Br J Surg 1996;83:1065–1070.
15.
Shimada K, Sakamoto Y, Sano T, Kosuge T: Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery 2006;139:288–295.
16.
Brennan MF, Moccia RD, Klimstra D: Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996;223:506–512.
17.
Sperti C, Pasquali C, Pedrazzoli S: Ductal adenocarcinoma of the body and tail of the pancreas. J Am Coll Surg 1997;185:255–259.
18.
Falconi M, Mantovani W, Bettini R, Talamini G, Bassi C, Cascinu S, et al: Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? Dig Liver Dis 2003;35:421–427.
19.
Nakao A, Harada T, Nonami T, Kanedo S, Nomoto H, Koyama K, et al: Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg 1997;84:1090–1092.
20.
Goh BK, Tan YM, Cheow PC, Chung YF, Chow PK, Wong WK, Ooi LL: Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. Am J Surg 2006;192:148–154.
21.
Goh BK, Tan YM, Chung YF, Chow PK, Cheow PC, Wong WK, Ooi LL: A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg 2006;30:2236–2245.
22.
Lai EC, Lau WY: Intraductal papillary mucinous neoplasms of the pancreas. Surgeon 2005;3:317–324.
23.
Lim JE, Chien MW, Earle CC: Prognostic factors following curative resection for pancreatic ductal carcinoma. Ann Surg 2003;237:74–85.
24.
Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas, 201 patients. Ann Surg 1995;221:721–731.
25.
Winter JM, Cameron JL, Campbell KA, et al: 1,423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006;10:1199–1211.
26.
Howard TJ, Krug JE, Yu J, et al: A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006;10:1338–1346.
27.
Tartter PI: The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633–638.
28.
Park SJ, Kim SW, Jang JY, Lee KU, Park YH: Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy? World J Surg 2002;26:487–492.
29.
Cameron JL, Crist DW, Sitzmann JV, et al: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120–125.
30.
Talamini MA, Moesinger RC, Pitt HA, et al: Adenocarcinoma of the ampulla of Vater: a 28-year experience. Ann Surg 1997;225:590–600.
31.
Nitecki SS, Sarr MG, Colby TV, et al: Long-term survival after resection for ductal adenocarcinom of the pancreas: is it really improving? Ann Surg 1995;221:59–66.
32.
Koninger J, Moritz MN, Muller MW, Gutt CN, Freiss H, Buchler MW: Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg 2007;392:13–21.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
